Taken together, these data suggested the RIC8A-Gα-RHOA-YAP signaling axis is involved in the regulation of EGFR TKI sensitivity in EGFR-mutant NSCLC cells. This evidence concerns the gene YAP1 and non-small cell lung carcinoma.